Evicenter
P&T meetings

Imlifidase

Kidney transplantation in highly sensitized patients

Manufacturer
Hansa Biopharma
Regulatory submission
BLA submitted December 2025
Last updated
85 sources

Product information and disease descriptionPlace of product in therapyDisease descriptionBurden of Kidney transplantation in highly sensitized patients

Economic impact of Kidney transplantation in highly sensitized patients on families

1 evidence topic · 1 source

Costs borne by families of highly sensitized adult transplant candidates

No evidence found.